SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mike head who wrote (919)7/12/1998 3:40:00 PM
From: Manny Gugliuzza   of 1510
 
What are we looking for as an end stage to conclusion for this study?

About 6 months at least is it not? especially with the newer antiretroviral, before they can start estimating the withdrawal effect from the drugs and the Remune's ability to enable the bodies defenses to fight, possibly longer.

Again this puts the focus for this stock in the 1st Q 99 and maybe 2nd
along with the end of Phase III. this will mark the next strong wave and then earnings should rule.

anyone with some working stock price action hypothesis for the interim?

My 1st thought was for a higher level trading range marked by the last high and similar to trading when we rose from 7 to 14 in 96 only much shorter in duration.

could make for some interesting play for the 15 and 17.5 options what do you think Don?

any other opinions?

ar.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext